Iterion Therapeutics logo
Healthcare & Life Sciences

Iterion Therapeutics

Iterion Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.

Activeseries-b
series-b
Stage
1
Investors

About Iterion Therapeutics

Based in the United States, Iterion Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Clinical-stage biopharmaceutical company developing tegavivint, a first-in-class small-molecule inhibitor of Wnt/β-catenin signaling for cancer. Its lead clinical focus is advanced hepatocellular carcinoma.

Explore Iterion Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States